Pharmafile Logo

transcreation

- PMLiVE

There’s always one more thing to learn

The importance of continuing professional development and achieving learning objectives

EU flag

European Commission grants two new marketing authorisations for UCB’s Bimzelx

The drug is now approved to treat psoriatic arthritis and axial spondyloarthritis

- PMLiVE

AstraZeneca/Sanofi’s RSV antibody backed by FDA advisory committee for infants

RSV is the leading cause of hospitalisation for infants aged under one year in the US

- PMLiVE

Janssen shares positive phase 3 results for cilta-cel in multiple myeloma

An estimated 35,000 new cases of multiple myeloma will be diagnosed in the US this year

- PMLiVE

Parkinson’s disease: past, present and future

Examining the history and complexities of Parkinson’s disease – one of the most prevalent neurodegenerative disorders that affects over 10 million people worldwide

How to Increase Engagement During Virtual Events

Here's tip 8 of 10 on how to increase engagement during virtual events. Learn more tips at  https://www.impetusdigital.com/2021/03/25/top-10-tips-to-increase-engagement-during-virtual-events/ To find out more about how Impetus Digital can aid pharma and life...

Impetus Digital

- PMLiVE

AstraZeneca to stop post-marketing study of Andexxa following early success

The company will now seek full approvals for the bleeding reversal agent in the US and EU

- PMLiVE

Janssen shares positive phase 3 results for erdafitinib in bladder cancer

Urothelial carcinoma accounts for approximately 90% of bladder cancer cases

- PMLiVE

Generative AI is coming for healthcare

Don’t say I didn’t warn you

- PMLiVE

GSK’s RSV vaccine approved by European Commission for older adults

RSV infections in older adults account for over 170,000 hospitalisations each year in Europe

- PMLiVE

Merck sues US government over Medicare drug price negotiation programme

The drugmaker says the programme violates the First and Fifth Amendments to the US Constitution

- PMLiVE

The 17th World Congress on Controversies in Neurology

This year, there was a focus on the rare disease neuromyelitis optica spectrum disorder that strikes suddenly and mainly impacts women

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links